Costimulation of CD28- T Lymphocytes by 4-1BB Ligand

Journal of Immunology

Volumn 158, Issue 2, 1997, Pages 551-559

  DeBenedette, Mark A ^a   Shahinian, Arda ^b   Mak, Tak W ^a,b   Watts, Tania H ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIGEN; CD137 ANTIGEN; CD137 LIGAND; CD28 ANTIGEN; CD3 ANTIGEN; LEUKOCYTE ANTIGEN; MEMBRANE PROTEIN; MONOCLONAL ANTIBODY; NERVE GROWTH FACTOR RECEPTOR; TNFRSF9 PROTEIN, MOUSE; TNFSF9 PROTEIN, MOUSE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

ANIMAL; ANTIGEN PRESENTING CELL; ARTICLE; BIOSYNTHESIS; C57BL MOUSE; DRUG EFFECT; FEMALE; IMMUNOLOGY; METABOLISM; MIXED LYMPHOCYTE CULTURE; MOUSE; SIGNAL TRANSDUCTION; T LYMPHOCYTE SUBPOPULATION;

4-1BB LIGAND; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGEN-PRESENTING CELLS; ANTIGENS, CD; ANTIGENS, CD137; ANTIGENS, CD28; ANTIGENS, CD3; FEMALE; ISOANTIGENS; LYMPHOCYTE CULTURE TEST, MIXED; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; RECEPTORS, NERVE GROWTH FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR; SIGNAL TRANSDUCTION; T-LYMPHOCYTE SUBSETS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0031567896     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Lenschow, D. J., T. L. Walunas, and J. A. Bluestone. 1996. CD28/B7 system of T cell costimulation. Annu. Rev. Immunol. 14:233.
2. Shahinian, A., K. Pfeffer, K. P. Lee, T. M. Kundig, K. Kishihara, A. Wakeham, K. Kawai, P. S. Ohashi, C. B. Thompson, and T. W. Mak. 1993. Differential T cell costimulatory requirements in CD28-deficient mice. Science 261:609.
3. Green, J. M., P. J. Noel, A. I. Sperling, T. L. Walunas, G. S. Gray, J. A. Bluestone, and C.B. Thompson. 1994. Absence of B7-dependent responses in CD28-deficient mice. Immunity 1:501.
4. Lucas, P. J., I. Negishi, K-I. Nakayama, L. E. Fields, and D. Y. Loh. 1995. Naive CD28-deficient T cells can initiate but not sustain an in vitro antigen-specific immune response. J. Immunol. 154:5757.
5. Kawai, K., A. Shahinian, T. W. Mak, and P. S. Ohashi. 1996. Skin allograft rejection in CD28-deficient mice. Transplantation 61:352.
6. Kwon, B. S., and S. M. Weissman. 1989. cDNA sequences of two inducible T-cell genes. Proc. Natl. Acad. sci. USA 86:1963.
7. Pollok, K. E., Y-J. Kim, Z. Zhou, J. Hurtado, K. K. Kim, R. T, Pickard, and B. S. Kwon. 1993. Inducible T cell antigen 4-1BB. J. Immunol. 150:771.
8. Smith, C. A., T. Farrah, and R. G. Goodwin. 1994. The TNF receptor superfamily of cellular and viral proteins: activation, costimularion, and death. Cell 76:959.
9. Goodwin, R. G., W. S. Din, T. Davis-Smith, D. M. Anderson, S. D. Gimpel, T. A. Sato, C. R. Maliszewski, C. I. Brannan, N. G. Copeland, N. A. Jenkins, T. Farrah, R. J. Armitage, W. C. Fanslow, and C. A. Smith. 1993. Molecular cloning of a ligand for the inducible gene 4-1BB: a member of an emerging family of cytokines with homology to tumor necrosis factor. Eur. J. Immunol. 23:2631.
10. Alderson, M. R., C. A. Smith, T. W. Tough, T. Davis-Smith, R. J. Armitage, B. Falk, E, Roux, E. Baker, G. R. Sutherland, W. S. Din, and R. G. Goodwin. 1994. Molecular and biological characterization of human 4-1BB and its ligand. Eur. J. Immunol. 24:2219.
11. Pollok, K. E., Y-J. Kim, J. Hurtado, Z. Zhou, K. K. Kim, and B. S. Kwon. 1994. 4-1BB: T-cell antigen binds to mature B cells and macrophages and costimulates anti-μ primed splenic B cells. Eur. J. Immunol. 24:367.
12. DeBenedette, M. A., N. R. Chu, K. E. Pollok, J. Hurtado, W. F. Wade, B. S. Kwon, and T. H. Watts. 1995. Role of 4-1BB ligand in costimulation of T lymphocyte growth and its up-regulation on M12 B lymphomas by cAMP. J. Exp. Med. 181:985.
13. Hurtado, J. C., S. H. Kim, K. E. Pollok, Z. H. Lee, and B. S. Kwon. 1995. Potential role of 4-1BB in T cell activation: comparison with costimulatory molecule CD28. J. Immunol. 155:3360.
14. Kim, K. J., C. Kanellopoulous-Langevin, R. M. Merwin, D. H. Sachs, and R. A. Asofsky. 1979. Establishment and characterization of BALB/c lymphoma lines with B cell properties. J. Immunol. 122:548.
15. Leo. O., M. Foo, D. H. Sachs, L. E. Samelson, and J. A. Bluestone. 1987. Identification of a monoclonal antibody specific for a murine T3 polypeptide. Proc. Natl. Acad. Sci. USA 84:1374.
16. Goldstein, M., M. A. DeBenedette, D. Hollenbaugh, and T. H. Watts. 1996. Induction of costimulatory molecules B7-1 and B7-2 in murine B cells: the CBA/N mouse reveals a role for Bruton's tyrosine kinase in CD40 mediated B7 induction. Mol. Immunol. 33:541.
17. Metlay, J. P., M. D. Witmer-Pack, R. Agger, M. T. Crowley, D. Lawless, and R. M. Steinman. 1990. The distinct leukocyte integrins of mouse spleen dendritic cells as identified with new hamster monoclonal antibodies. J. Exp. Med. 171: 1753.
18. Goding, J. W. 1983. Monoclonal Antibodies: Principles and Practice. Academic Press, London, pp. 230-233.
19. Ranheim, E. A., and T. J. Kipps. 1993. Activated T cells induce expression of B7/BB1 on normal or leukemic B cells through a CD40 dependent signal. J. Exp. Med. 177:925.
20. Roy, M., A. Aruffo, J. Ledbetter, P. Linsley, M. Kehry, and R. Noelle. 1995. Studies on the interdependence of gp39 and B7 expression and function during antigen specific immune responses. Eur. J. Immunol. 25:596.
21. Steinman, R. M. 1991. The dendritic cell system and its role in immunogenicity. Annu. Rev. Immunol. 9:271.
22. Larsen, C. P., S. C. Richie, T. C. Pearson, P. S. Linsely, and R. P. Lowry. 1992. Functional expression of the costimulatory molecule, B7/BB1, on mutine dendritic cell populations. J. Exp. Med. 176:1215.
23. Larsen, C. P., S. C. Richie, R. Hendrix, P. S. Linsely, K. S. Hathcock, R. J. Hodes, R. Lowry, and T. C. Pearson. 1994. Regulation of immunostimulatory function and costimulatory molecule (B7-1 and B7-2) expression on murine dendritic cells. J. Immunol. 152:5208.
24. Barrett, T. B., G. Shu, and E. A. Clark, 1991. CD40 signaling activates CD11a/ CD18 (LFA-1)-mediated adhesion in B cells. J. Immunol. 146:1722.
25. + T lymphocytes. J. Immunol. 151:2368.
26. + T cells: ICAM-1 or B7-1 can costimulate naive CD4 T cell activation but both are required for optimum response. J. Immunol. 155:45.
27. Wu. Y., J. Xu, S. Shinde, I. Grewal, T. Henderson, R. A. Flavell, and Y. Liu. 1995. Rapid induction of a novel costimulatory activity on B cells by CD40 ligand. Curr. Biol. 5:1303.
28. Ding, L., and E. M. Shevach. 1996. Activated B cells express CD28/B7-independent costimulatory activity. J. Immunol. 157:1389.
29. Goodwin, R. G., M. R. Alderson, C. R, Smith, R. J. Armitage, T. VandenBos, R. Jerzy, T. W. Tough, M. A. Shoenborn, T. Davis-Smith, K. Henne, B. Falk, D. Cosman, E. Baker, G. R. Sutherland, K. H. Grabstein, T. Farrah, J. G. Giri, and M. P. Beckman. 1993. Molecular and biological characterization of a ligand for CD27 defines a new family of cytokines with homology to tumour necrosis factor. Cell 73:447.
30. Del Prete, G., M. De Carli, M. D. D'Elios, K. C. Daniel, F. Almerigogna, M. Alderson, C. A. Smith, E. Thomas, and S. Romagnani. 1995. CD30-mediated signaling promotes the development of human T helper type 2 like cells. J. Exp. Med. 182:1655.
31. + T cell responses. Curr. Biol. 4:499.